Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Saved in:
Bibliographic Details
Title: Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
Authors: Deshpande SR; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Podder TK; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio., Grubb W; Department of Radiation Oncology, Medical College of Georgia, Augusta, Georgia., Zhang Y; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio., Zheng Y; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio., Towe C; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio., Linden P; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio., Avril N; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Radiology, Nuclear Medicine, University Hospitals, Cleveland, Ohio., Biswas T; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.
Source: Advances in radiation oncology [Adv Radiat Oncol] 2023 Jul 09; Vol. 9 (1), pp. 101313. Date of Electronic Publication: 2023 Jul 09 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN: 2452-1094 (Print) Linking ISSN: 24521094 NLM ISO Abbreviation: Adv Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38260218
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Deshpande+SR%22">Deshpande SR</searchLink>; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Podder+TK%22">Podder TK</searchLink>; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Grubb+W%22">Grubb W</searchLink>; Department of Radiation Oncology, Medical College of Georgia, Augusta, Georgia.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Towe+C%22">Towe C</searchLink>; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Linden+P%22">Linden P</searchLink>; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Division of Cardiothoracic Surgery, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Avril+N%22">Avril N</searchLink>; School of Medicine, Case Western Reserve University, Cleveland, Ohio.; Department of Radiology, Nuclear Medicine, University Hospitals, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Biswas+T%22">Biswas T</searchLink>; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, Cleveland, Ohio.; School of Medicine, Case Western Reserve University, Cleveland, Ohio.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101677247%22">Advances in radiation oncology</searchLink> [Adv Radiat Oncol] 2023 Jul 09; Vol. 9 (1), pp. 101313. <i>Date of Electronic Publication: </i>2023 Jul 09 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101677247 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2452-1094 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224521094%22">24521094 </searchLink><i>NLM ISO Abbreviation: </i>Adv Radiat Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38260218
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.adro.2023.101313
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 101313
    Titles:
      – TitleFull: Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Deshpande SR
      – PersonEntity:
          Name:
            NameFull: Podder TK
      – PersonEntity:
          Name:
            NameFull: Grubb W
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Zheng Y
      – PersonEntity:
          Name:
            NameFull: Towe C
      – PersonEntity:
          Name:
            NameFull: Linden P
      – PersonEntity:
          Name:
            NameFull: Avril N
      – PersonEntity:
          Name:
            NameFull: Biswas T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 07
              Text: 2023 Jul 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2452-1094
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Advances in radiation oncology
              Type: main
ResultId 1